Skip to main content


  • Sunday, Aug 24th
    10:45 AM - 11:00 AM ET
    1E-02 - Risk of Opioid Overdose Associated with Concurrent Use of Hydrocodone and CYP3A4-inhibiting Calcium Channel Blockers
    Presenting Author: Sungho Bea, PharmD, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
    Co-Author: C. Andrew Basham – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
    Co-Author: Heba H. Edrees – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
    Co-Author: Krista Huybrechts – Brigham and Women's Hospital and Harvard Medical School
    Co-Author: Seanna Vine – Brigham and Women's Hospital and Harvard Medical School
    Co-Author: Robert Glynn – Brigham and Women's Hospital
    Co-Author: Brian Bateman – Stanford University School of Medicine
    Co-Author: Katsiaryna Bykov, PharmD, ScD – Brigham and Women's Hospital
    Safety Outcomes / Other
  • Sunday, Aug 24th
    11:00 AM - 11:15 AM ET
    1E-03 - Opioid Overdose Associated With Concomitant Use of Hydrocodone And Selective Serotonin Reuptake Inhibitors
    Presenting Author: Sungho Bea, PharmD, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
    Co-Author: Krista Huybrechts – Brigham and Women's Hospital and Harvard Medical School
    Co-Author: Robert Glynn – Brigham and Women's Hospital
    Co-Author: Seanna Vine – Brigham and Women's Hospital and Harvard Medical School
    Co-Author: Shruti Belitkar – Brigham and Women's Hospital
    Co-Author: Brian Bateman – Stanford University School of Medicine
    Co-Author: Katsiaryna Bykov, PharmD, ScD – Brigham and Women's Hospital
    Safety Outcomes / Other
  • Sunday, Aug 24th
    11:30 AM - 11:45 AM ET
    1E-05 - Risk of Major Bleeding with Concomitant Use of Selective Serotonin Reuptake Inhibitors and Antithrombotics: a Nationwide Case-Case-Time-Control Study
    Presenting Author: Ju Hwan Kim, PharmD, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
    Co-Author: Bin Hong – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
    Co-Author: Hyesung Lee, PhD – Department of Medical Informatics, Kangwon National University College of Medicine, Chuncheon, South Korea
    Co-Author: Ha Yun Choi – Veterns Health Service Medical Center
    Co-Author: Ju-Young Shin, PharmD, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
    Safety Outcomes / Other
  • Sunday, Aug 24th
    4:15 PM - 4:30 PM ET
    2B-04 - Leveraging natural language processing (NLP) for the detection of drug-induced anaphylaxis in clinical notes
    Presenting Author: Veronique Shiwa, PharmD – Department of Pharmaceutical and Pharmacological Sciences
    Co-Author: Yves Thorrez – Department of Medical Informatics
    Co-Author: Pieter Cornu, PhD, PharmD, MSc Epidemiology – Department of Pharmaceutical and Pharmacological Sciences
    Safety Outcomes / Other
  • Sunday, Aug 24th
    4:15 PM - 4:30 PM ET
    2G-04 - Prenatal Opioid Exposure and the Risk of Adverse Neonatal and Neurodevelopmental Outcomes: A Systematic Review and Meta-Analysis
    Presenting Author: Sophia DiMuccio, n/a – University of Rhode Island
    Co-Author: Xuerong Wen, PhD, MS, MPH – University of Rhode Island
    Co-Author: Marianne N. Otoo, MPharm, BPharm – University of Rhode Island
    Co-Author: Israel Adenekan – University of Rhode Island
    Co-Author: Yichi Zhang, PhD, MS, BS – University of Rhode Island
    Co-Author: Todd Brothers, PharmD, BCCCP, BCPS – University of Rhode Island
    Co-Author: Kristina E. Ward, PharmD, BCPS – University of Rhode Island
    Safety Outcomes / Other
  • Monday, Aug 25th
    9:15 AM - 9:20 AM ET
    3C-09 - Exploring the Impact of Implementing Automated Dispensing Cabinet Systems on Patient Safety and Human Resource Management in Inpatient Pharmacy Service at a Medical Center in Taiwan
    Presenting Author: Yu-Sheng Chu – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
    Co-Author: CHING-LAN CHENG, PhD – National Cheng Kung University
    Co-Author: Yea-Huei Kao Yang – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
    Safety Outcomes / Other
  • Monday, Aug 25th
    9:15 AM - 9:30 AM ET
    3B-05 - Risk of Major Adverse Cardiovascular Events in Patients Receiving Roflumilast for the Treatment of Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study Using Target Trial Emulation Framework
    Presenting Author: Hung-Kai Chen – Department of Pharmaceutical Outcomes and Policy, University of Florida
    Co-Author: Shao-Hsuan Chang – University of Florida
    Co-Author: Yehua Wang, MSPH – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA
    Co-Author: Tianze Jiao – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida
    Co-Author: Almut G. Winterstein, PharmD, PhD – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA
    Safety Outcomes / Other
  • Tuesday, Aug 26th
    9:30 AM - 9:45 AM ET
    5E-05 - Acute eGFR Dip with SGLT2 Inhibitors vs. Other Antihyperglycemic Medications Among People with HIV
    Presenting Author: Lara Haidar – College of Pharmacy, University of Manitoba
    Co-Author: Robin M. Nance – University of Washington
    Co-Author: L.Sarah Mixson – University of Washington
    Co-Author: Bridget Whitney – University of Washington
    Co-Author: Carolyn Fahey – University of Washington
    Co-Author: Stephanie A. Ruderman – University of Washington
    Co-Author: Laila Aboulatta – College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada
    Co-Author: Greer Burkholder – University of Alabama, Birmingham
    Co-Author: Richard D. Moore, MD – Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America
    Co-Author: Robert Kalayjian – MetroHealth Medical Center
    Co-Author: Laura Bamford – University of California, San Diego
    Co-Author: Katerina Christopoulos – University of California, San Francisco
    Co-Author: Alexander Commanday – University of North Carolina at Chapel Hill
    Co-Author: April Pettit – Vanderbilt University
    Co-Author: Joseph A. C. Delaney – University of Washington
    Co-Author: Heidi M. Crane – University of Washington
    Co-Author: Sherif Eltonsy – College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada
    Safety Outcomes / Other
  • Tuesday, Aug 26th
    2:15 PM - 2:30 PM ET
    6G-04 - Risk of Osteoporosis, Osteoporotic Fractures, and Falls in Patients With Rheumatoid Arthritis Receiving JAK Inhibitors: A Target Trial Emulation Study
    Presenting Author: Vincent Ping-Sheng Chou – National Cheng Kung University
    Co-Author: Avery Shuei-He Yang, MClinPharm – School Of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University
    Co-Author: Albert Tzu-Ming Chuang, PharmD – Population Health Data Center, National Cheng Kung University, Tainan, Taiwan
    Co-Author: Daniel Hsiang-Te Tsai – Population Health Data Center, National Cheng Kung University, Tainan, Taiwan
    Co-Author: Edward Chia-Cheng Lai, PhD – Population Health Data Center, National Cheng Kung University
    Safety Outcomes / Other